R&D
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
Availability of C2N’s First Blood-Based Diagnostic Marks Breakthrough in Alzheimer’s Disease
2020-10-30
Exact Sciences Looks to Thrive in Blood-Based, Early Cancer Detection Space with Two New Buyouts
2020-10-29
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
Novartis’s Iptacopan Shows Promising Results as First in Class Oral Therapy for Rare Renal Disease
2020-10-28
Foundation Medicine’s CGP Test FDA Approved as Companion Diagnostic for Bayer’s Tumor Agnostic Therapy
2020-10-26
Retrophin Acquires Orphan Technologies to Develop Potential, Effective Cure for Rare Disease
2020-10-25